75985-45-4

Basic information

• Product Name: 2-PYRIMIDINEMETHANAMINE
• Synonyms: RARECHEM AL BW 0784;PYRIMIDIN-2-YL-METHYLAMINE;C-PYRIMIDIN-2-YL-METHYLAMINE;2-PYRIMIDINEMETHANAMINE;2-Pyrimidinemethanamine (9CI);C-PyriMidin-2-yl-MethylaMine, fuMMerate
• CAS NO: 75985-45-4
• Molecular Formula: C₅H₇N₃
• Molecular Weight: 109.13
• EINECS: 1806241-263-5
• Product Categories: PYRIMIDINE;Heterocycle-Pyrimidine series
• Mol File: 75985-45-4.mol
• Article Data: 6

Chemical Properties

• Boiling Point: 179.9 °C at 760 mmHg
• Flash Point: 83.7 °C
• Appearance: /
• Density: 1.138 g/cm³
• Vapor Pressure: 0.919mmHg at 25°C
• Refractive Index: 1.557
• Storage Temp.: 2-8°C(protect from light)
• Solubility: Chloroform (Sparingly), Methanol (Slightly)
• CAS DataBase Reference: 2-PYRIMIDINEMETHANAMINE(CAS DataBase Reference)
• NIST Chemistry Reference: 2-PYRIMIDINEMETHANAMINE(75985-45-4)
• EPA Substance Registry System: 2-PYRIMIDINEMETHANAMINE(75985-45-4)

Safety Data

• Hazard Codes: Xi
• Statements: 36/37/38
• Safety Statements: 26
• Hazardous Substances Data: 75985-45-4(Hazardous Substances Data)

Usage

Chemical Properties

white powder

Uses

2-Pyrimidinemethanamine can be prepared to combat abiotic plant stress.

InChI:InChI=1/C5H7N3/c6-4-5-7-2-1-3-8-5/h1-3H,4,6H2

Synthetic route

2-cyanopyrimidine (14080-23-0) → 2-aminomethylpyrimidine (75985-45-4)

Conditions	Yield
With palladium 10% on activated carbon; hydrogen In ethanol under 760.051 Torr; for 12h; Inert atmosphere;	95%
With hydrogenchloride; palladium 10% on activated carbon; hydrogen In methanol; water at 20℃; for 3h;	44%
With hydrogen; Pd-C; ammonia In ethanol

4-{[(3-chloro-4-methoxyphenyl)methyl]amino}-2-[(2S)-2-(hydroxymethyl)pyrrolidin-1-yl]pyrimidine-5-carboxylic acid (330785-84-7) + 2-aminomethylpyrimidine (75985-45-4) → avanafil (330784-47-9)

Conditions	Yield
With dicyclohexyl-carbodiimide; 1-hydroxy-1,2,3-benzotriazine-4(3H)-one In N,N-dimethyl-formamide at 0℃; Temperature;	99%
With 5, 10, 15, 20-tetrakis[4-(dihydroxyboryl)phenyl]-21H,23H-porphine In toluene for 16h; Time; Reflux; Green chemistry;	91.2%
With benzotriazol-1-ol; dicyclohexyl-carbodiimide In dimethyl sulfoxide at 20℃; for 4h;	90%
With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In DMF (N,N-dimethyl-formamide) at 20℃; for 8h;

2-methyl-1-(2,6,8-trichloropyrimido[5,4-d]pyrimidin-4-ylamino)propan-2-ol + 2-aminomethylpyrimidine (75985-45-4) → 1-{2,6-dichloro-8-[(pyrimidin-2-ylmethyl)amino]pyrimido[5,4-d]pyrimidin-4-ylamino}-2-methylpropan-2-ol

Conditions	Yield
With N-ethyl-N,N-diisopropylamine In butan-1-ol at 70℃; for 2h;	97%

(3-chloro-4-methoxyphenyl)methanamine (115514-77-7) + C6H6N2O5S + 2-aminomethylpyrimidine (75985-45-4) → 4-[(3-chloro-4-methoxybenzyl)amino]-2-methanesulfonyl-N-(2-pyrimidinylmethyl)-5-pyrimidinecarboxamide

Conditions	Yield
Stage #1: C6H6N2O5S With N-ethyl-N,N-diisopropylamine; trichlorophosphate In toluene Reflux; Stage #2: 2-aminomethylpyrimidine With N-ethyl-N,N-diisopropylamine In toluene at -8℃; Stage #3: (3-chloro-4-methoxyphenyl)methanamine With N-ethyl-N,N-diisopropylamine In toluene at 0℃; Temperature;	93.8%

C18H21ClN4O4 + 2-aminomethylpyrimidine (75985-45-4) → C23H26ClN7O3

Conditions	Yield
With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In N,N-dimethyl-formamide at 20℃;	92%

6-(3-chloro-4-methoxy - benzyl-amino)-2 (2-hydroxymethyl-pyrrolidinyl) pyrimidine-5-carboxylic acid + 2-aminomethylpyrimidine (75985-45-4) → C23H28ClN7O3

Conditions	Yield
Stage #1: 6-(3-chloro-4-methoxy - benzyl-amino)-2 (2-hydroxymethyl-pyrrolidinyl) pyrimidine-5-carboxylic acid With 1,1'-carbonyldiimidazole In N,N-dimethyl-formamide at 40 - 50℃; for 3h; Stage #2: 2-aminomethylpyrimidine In N,N-dimethyl-formamide at 60 - 70℃;	90%

C14H14ClN3O5S + 2-aminomethylpyrimidine (75985-45-4) → 4-[(3-chloro-4-methoxybenzyl)amino]-2-methanesulfonyl-N-(2-pyrimidinylmethyl)-5-pyrimidinecarboxamide

Conditions	Yield
Stage #1: C14H14ClN3O5S With thionyl chloride; N,N-dimethyl-formamide In toluene Reflux; Green chemistry; Stage #2: 2-aminomethylpyrimidine With triethylamine In toluene at 0℃; Green chemistry;	89.5%

Upstream product

• 14080-23-0 2-cyanopyrimidine 

Downstream Products

• 372118-45-1 4-(3-chloro-4-methoxybenzylamino)-5-[N-(2-pyrimidinylmethyl)carbamoyl]-6-methoxy-2-methylthiopyrimidine 
• 1595285-84-9 (E)-N-(4-((3-chloro-4-fluorophenyl)amino)thieno[2,3-d]pyrimidin-6-yl)-4-((pyrimidin-2-ylmethyl)amino)but-2-enamide 
• 1260843-26-2 tert-butyl (pyrimidin-2-ylmethyl)carbamate 
• 792184-90-8 N-(4-fluorophenyl)-N'-phenyl-N-(pyrimidin-2-ylmethyl)-1,3,5-triazine-2,4,6-triamine 
• 330784-47-9 avanafil 

Relevant articles and documents

MANUFACTURING METHOD OF OPTICAL ACTIVE SECONDARY ALCOHOL

PROBLEM TO BE SOLVED: To provide a method for manufacturing optical active secondary alcohol with high optical purity by hydrogenating a substrate carbonyl compound using a ruthenium complex with a specific optical active diphosphine compound and an amine compound of which synthesis is easy as ligands as a catalyst. SOLUTION: The manufacturing method of optical active secondary alcohol including reacting a substrate carbonyl compound (excluding 3-quinuclidinone, a 3-quinuclidinone derivative having a substituent, and ketone having an aromatic hydrocarbon group and a heterocycle) with hydrogen and/or a hydrogen-donating compound in a presence of a ruthenium complex selected from a compound represented by the following general formula (1) RuXYAB (1) [X and Y are same or different, represent a hydrogen atom or an anionic group, A represents optical active diphosphine represented by the general formula (2), and B represents an amine compound represented by the following general formula (3)]. SELECTED DRAWING: None COPYRIGHT: (C)2019,JPO&INPIT

SPIRO-LACTAM NMDA RECEPTOR MODULATORS AND USES THEREOF

Disclosed are compounds having enhanced potency in the modulation of NMD A receptor activity. Such compounds are contemplated for use in the treatment of conditions such as depression and related disorders. Orally available formulations and other pharmaceutically acceptable delivery forms of the compounds, including intravenous formulations, are also disclosed.

7-azaisoindolinyl-quinolone-carboxylic acid derivatives

The invention relates to new quinolonecarboxylic acid derivatives which are substituted in the 7-position by an optionally partially hydrogenated azaisoindolinyl ring, to processes for their preparation, and to antibacterial agents and feed additives containing them.